首页> 美国卫生研究院文献>Canadian Medical Association Journal >The Use of Corticosteroid (Dexamethasone) in the Treatment of Acute Laryngotracheitis
【2h】

The Use of Corticosteroid (Dexamethasone) in the Treatment of Acute Laryngotracheitis

机译:皮质类固醇(地塞米松)在治疗急性喉气管炎中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many practitioners have considered that steroids, with their anti-inflammatory properties, should be efficacious in the treatment of acute laryngotracheitis. To examine this theory, 200 consecutive cases of acute laryngotracheitis admitted to The Hospital for Sick Children, Toronto, were included in a double-blind study using dexamethasone-21-phosphate and placebo according to a random selection code. All other therapy was kept constant. Each patient was assessed by one observer according to seven clinical parameters.The results of this study were subjected to statistical analysis and significantly favoured the steroid-treated group in four parameters only. In view of the risks inherent in steroid therapy, this degree of difference is not sufficient to warrant routine use of this drug for patients with acute laryngotracheitis.
机译:许多从业者认为,类固醇具有抗炎特性,在治疗急性喉气管炎中应有效。为了检验这一理论,根据随机选择代码,使用地塞米松-21-磷酸酯和安慰剂的双盲研究纳入了多伦多疾病儿童医院住院的连续200例急性喉气管炎病例。所有其他疗法均保持不变。每位患者由一名观察者根据七个临床参数进行评估。本研究的结果经过统计学分析,仅在四个参数上显着偏重于激素治疗组。考虑到类固醇治疗固有的风险,这种程度的差异不足以保证对急性喉气管炎患者常规使用该药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号